Limitless Venture Group Inc (OTCMKTS:LVGI) reported that it received the necessary government nod for the labels of its SLAM product line of shots. With all label and flavor approvals received, Temperance Distillery in State of Michigan will now be scheduled to commence production of SLAM. Joe Francella, the CEO said that they are extremely delighted that the official approvals have been received and the long wait of release of SLAM product line to the public comes to an end.
The momentum
Lately the stock price of Limitless Venture posted an impressive run after registering steep losses. The stock was trading close to $0.0003 for a long time before it started an upward move to enter into double zero land. However, in yesterday’s trading session, it once again declined more than 12% to close the trading session at $0.00070. The stock declined more than 33% on Friday’s trading session to close at $0.0008. The recent momentum in the stock states that it won’t be easy LVGI to trade in double zero land.
What’s the buzz?
The volatile momentum in Limitless Venture Group Inc (OTCMKTS:LVGI) is not supported by anything apparent. There were no new Press releases issued or promotional emails launched to support the stock. However, there is some buzz on investor forums as people are discussing about the ‘HempCore’ Health product being sold. The problem is the lack of any official PR to confirm the news.
The financials
The financials of Limitless Venture are terrible which is evident from the financial report filed for the quarter ended March 31. As per the report, the company had cash of $19,000 at the end of quarter. The current assets stood at $24,000 and current liabilities were $1.9 million. The revenue in quarter was zero and net loss was $125,000. The company has to report some revenue so as to attract the attention of investors.
